RxDoctor Payments Data

Justin Hall, MD

Orthopaedic Surgery of the Spine · Columbus, MSNPI 1558521021

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $31,750 of the $51,520 with a category attached, or 61.6%. Orthofix Medical, Inc. accounts for 82.7% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $21,550 and has fallen 85.4% since, to $3,138 in 2025.

$51,520in general payments, 2019–2025

Across 103 payments — averaging $500.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Orthofix Medical, Inc.$43K
  • Zavation Medical Products, LLC$8K
  • Boston Scientific$583
  • Johnson & Johnson$124
  • Gentleman Orthopedic Solutions$86
  • Spine Wave, Inc.$58
  • plus $120 from 5 others
$131,200in research payments, 2019–2025

Across 20 payments — averaging $6560.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Orthofix Medical, Inc.$131K

What the payments were for

  • Consulting fees$9,76819%
  • Speaking & faculty fees$31,75062%
  • Travel & lodging$3,3807%
  • Food & beverage$3,0236%
  • Education$3,6007%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few orthopaedic surgery of the spine providers in Mississippito place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$501,459
Medicare patients
488
Services billed
4,763

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen189$1,352
Gabapentin120$922
Mupirocin86$515
Celecoxib55$397
Cyclobenzaprine Hcl45$293
Oxycodone Hcl70$255
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen13$245
Tramadol Hcl77$215
Methylprednisolone30$178
Pregabalin11$175
Methocarbamol13$168
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim25$123
Ciprofloxacin Hcl11$121
Tizanidine Hcl29$109
Cephalexin45$102

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Columbus

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →